The updated ICH Q5A(R2) draft guidance has been released

News Release The updated ICH Q5A(R2) draft guidance has been released PathoQuest, a leader in the development and provision of Next Generation Sequencing (NGS) testing services for the biopharmaceutical industry, is excited to announce that the updated ICH Q5A(R2)...

PathoQuest Announce the Opening of its New U.S. Facility

Press Release PathoQuest Announce the Opening of its New U.S. Facility The Leading Experts in NGS Biosafety Testing and Characterization of Biopharmaceuticals Launch New Capabilities in the Critical U.S. Market Wayne, PA, and Paris, France – October 4, 2022 –...
EnglishFrenchGermanSpanish